No­var­tis pays $15M up­front to li­cense Voy­ager pro­gram; Boehringer ad­vances ge­o­graph­ic at­ro­phy drug

Plus, news about Jnana Ther­a­peu­tics, Vax­cyte, C-Fur­ther, Gen­prex, Phar­maEssen­tia, FORUS Ther­a­peu­tics, Phar­ma Two B and He­p­i­on:

No­var­tis li­cens­es Voy­ager pro­gram: Voy­ager will get $15 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER